How to achieve a functional cure for chronic hepatitis B webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
Oramed Pharmaceuticals Inc. announced top-line results from its Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial comparing the efficacy of ORMD-0801 to placebo in. | January 12, 2023
SWEDEN: When compared to installation two to four weeks following an abortion, inserting an IUD within 48 hours of a complete abortion seemed safe and was linked to reduced pain scores, states a study.
In hospitalized patients with COVID-19 Pneumonia, the rates of clinical events among those treated with Reparixin (n=36) were statistically significantly lower than standard of care (n=19). The study is the first evaluation of the efficacy and safety of Reparixin an IL-8 inhibitor in patients with severe COVID-19 pneumonia. Results from the Phase 2 trial were presented at the American Thoracic Society (ATS) 2022 International Conference and published in Infectious Diseases and Therapy MILAN, June 13, 2022 /PRNewswire/ Dompe farmaceutici S.p.A ("Dompe") today announcedresults from its Phase 2 clinical trial demonstrating that, in patients in severe COVID-19 Pneumonia, Reparixin led to an improvement in clinical outcomes when compared with the standard of care, a larger phase 3 clinical study is needed to confirm these results. Results from the Phase 2 trial are published in Infectious Diseases and Therapy and were presented at the scientific sessions of the ATS 2022 Internati
MAASTRICHT, Netherlands, May 19, 2021 /PRNewswire/ Pie Medical Imaging ("PMI"), a global leader in cardiac imaging, today announced the conclusion of the FASTII trial and presentation of